Business Description
Procaps Group SA
NAICS : 325411
SIC : 2833
ISIN : LU2376511205
Description
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.27 | |||||
| 9-Day RSI | 56 | |||||
| 14-Day RSI | 57.05 | |||||
| 6-1 Month Momentum % | -65.8 | |||||
| 12-1 Month Momentum % | -73.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | 8.23 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 5.08 | |||||
| Forward PE Ratio | 18.43 | |||||
| PE Ratio without NRI | 88 | |||||
| EV-to-EBIT | 5.2 | |||||
| EV-to-Forward-EBIT | 8.35 | |||||
| EV-to-EBITDA | 4.46 | |||||
| EV-to-Revenue | 1.33 | |||||
| EV-to-Forward-Revenue | 1.24 | |||||
| Earnings Yield (Greenblatt) % | 19.23 | |||||
| FCF Yield % | 11.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PROC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Procaps Group SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 414.096 | ||
| EPS (TTM) ($) | 0.52 | ||
| Beta | 0.07 | ||
| Volatility % | 81.24 | ||
| 14-Day RSI | 57.05 | ||
| 14-Day ATR ($) | 0.442683 | ||
| 20-Day SMA ($) | 2.1545 | ||
| 12-1 Month Momentum % | -73.71 | ||
| 52-Week Range ($) | 0.5 - 4.95 | ||
| Shares Outstanding (Mil) | 112.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Procaps Group SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Procaps Group SA Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Procaps Group SA Frequently Asked Questions
What is Procaps Group SA(PROC)'s stock price today?
The current price of PROC is $2.48. The 52 week high of PROC is $4.95 and 52 week low is $0.50.
When is next earnings date of Procaps Group SA(PROC)?
The next earnings date of Procaps Group SA(PROC) is 2024-12-26 Est..
Does Procaps Group SA(PROC) pay dividends? If so, how much?
Procaps Group SA(PROC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers